PARP-3 polyclonal, anti-human
€422.00
In stock
SKU
251939
Protein Family: Enzymes
Pathway and Disease: Signaling Molecules and Interaction, Replication and Repair
Description:
Poly (ADP-ribose) polymerase (PARP) catalyzes the post-translational modification of proteins by the addition of multiple ADP-ribose moieties. PARP transfers ADP-ribose from nicotinamide dinucleotide (NAD) to glu/asp residues on the substrate protein, and also polymerizes ADP-ribose to form long/branched chain polymers. PARP inhibitors are being developed for use in a number of pathologies including cancer, diabetes, stroke and cardiovascular disease.
Alternate Names: Poly [ADP-ribose] polymerase 3, PARP-3, hPARP-3, NAD(+) ADP-ribosyltransferase 3, ADPRT-3, Poly[ADP-ribose] synthetase 3, pADPRT-3, IRT1, PARP3, ADPRT3, ADPRTL3
Application Notes: E: 1:1,000-1:10,000; WB: 1:100-1:500
Accession No.: Q9Y6F1
Antigen: KLH-conjugated synthetic peptide encompassing a sequence within human PARP-3.
Format: Each vial contains 0.1 mg IgG in 0.1 ml (1 mg/ml) of PBS pH7.4 with 0.09% sodium azide. Antibody was purified by Protein-G affinity chromatography.
Storage:
Store at -20°C. Minimize freeze-thaw cycles. Product is guaranteed one year from the date of shipment.
Pathway and Disease: Signaling Molecules and Interaction, Replication and Repair
Description:
Poly (ADP-ribose) polymerase (PARP) catalyzes the post-translational modification of proteins by the addition of multiple ADP-ribose moieties. PARP transfers ADP-ribose from nicotinamide dinucleotide (NAD) to glu/asp residues on the substrate protein, and also polymerizes ADP-ribose to form long/branched chain polymers. PARP inhibitors are being developed for use in a number of pathologies including cancer, diabetes, stroke and cardiovascular disease.
Alternate Names: Poly [ADP-ribose] polymerase 3, PARP-3, hPARP-3, NAD(+) ADP-ribosyltransferase 3, ADPRT-3, Poly[ADP-ribose] synthetase 3, pADPRT-3, IRT1, PARP3, ADPRT3, ADPRTL3
Application Notes: E: 1:1,000-1:10,000; WB: 1:100-1:500
Accession No.: Q9Y6F1
Antigen: KLH-conjugated synthetic peptide encompassing a sequence within human PARP-3.
Format: Each vial contains 0.1 mg IgG in 0.1 ml (1 mg/ml) of PBS pH7.4 with 0.09% sodium azide. Antibody was purified by Protein-G affinity chromatography.
Storage:
Store at -20°C. Minimize freeze-thaw cycles. Product is guaranteed one year from the date of shipment.
| Is Featured? | No |
|---|
Write Your Own Review